Xiangjuan Liu

1.1k total citations · 1 hit paper
23 papers, 933 citations indexed

About

Xiangjuan Liu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Xiangjuan Liu has authored 23 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Xiangjuan Liu's work include Cardiovascular Function and Risk Factors (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Xiangjuan Liu is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Xiangjuan Liu collaborates with scholars based in China, United States and Thailand. Xiangjuan Liu's co-authors include Yun Zhang, Fengshuang An, Mingxiang Zhang, Beibei Luo, Yanfei Xia, Cheng Zhang, Bo Li, Wenke Wang, Ben Wang and Qinghua Lu and has published in prestigious journals such as PLoS ONE, Frontiers in Plant Science and Carcinogenesis.

In The Last Decade

Xiangjuan Liu

21 papers receiving 922 citations

Hit Papers

NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy ... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangjuan Liu China 12 515 271 152 130 118 23 933
Chunpeng Zou China 14 310 0.6× 211 0.8× 92 0.6× 81 0.6× 147 1.2× 35 799
Chae‐Myeong Ha United States 16 688 1.3× 138 0.5× 169 1.1× 195 1.5× 89 0.8× 20 1.3k
Hong Ding China 18 529 1.0× 245 0.9× 182 1.2× 53 0.4× 105 0.9× 36 1.5k
Sungmi Park South Korea 17 397 0.8× 196 0.7× 83 0.5× 79 0.6× 88 0.7× 38 1.0k
Mitchel Tate Australia 17 512 1.0× 350 1.3× 212 1.4× 133 1.0× 112 0.9× 29 1.1k
Jianbin Gong China 17 312 0.6× 176 0.6× 132 0.9× 127 1.0× 104 0.9× 49 760
Hiroaki Sunaga Japan 17 321 0.6× 210 0.8× 94 0.6× 101 0.8× 71 0.6× 33 799
Hiroshi Satonaka Japan 16 507 1.0× 178 0.7× 159 1.0× 98 0.8× 106 0.9× 32 1.0k
Bardia Askari United States 15 802 1.6× 115 0.4× 208 1.4× 84 0.6× 118 1.0× 20 1.3k
Hailing Li China 16 336 0.7× 210 0.8× 86 0.6× 206 1.6× 101 0.9× 56 907

Countries citing papers authored by Xiangjuan Liu

Since Specialization
Citations

This map shows the geographic impact of Xiangjuan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjuan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjuan Liu more than expected).

Fields of papers citing papers by Xiangjuan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjuan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjuan Liu. The network helps show where Xiangjuan Liu may publish in the future.

Co-authorship network of co-authors of Xiangjuan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjuan Liu. A scholar is included among the top collaborators of Xiangjuan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjuan Liu. Xiangjuan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Lianyue, Wei Yang, Wei Gao, et al.. (2025). IL-17 as a therapeutic target in cardiovascular diseases: Mechanistic insights and translational opportunities. Pharmacological Research. 219. 107879–107879.
2.
Tian, Rui, et al.. (2025). Overexpression of KIF2C amplifies tamoxifen resistance and lung metastasis of breast cancer through PLK1/C-Myc pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(9). 12133–12146.
3.
Liu, Xiangjuan, et al.. (2024). Corn Yield Prediction Based on Dynamic Integrated Stacked Regression. Agriculture. 14(10). 1829–1829. 1 indexed citations
4.
Liu, Xiangjuan, et al.. (2024). Butylphthalide combined with donepezil for the treatment of vascular dementia: a meta-analysis. Journal of International Medical Research. 52(3). 3639284009–3639284009. 5 indexed citations
5.
Liu, Xiangjuan, Congcong Sun, Guipeng An, Lili Cao, & Meng Xiao. (2024). Case Report: Hypereosinophilic syndrome vs. patent foramen ovale as etiopathogenetic contributors to stroke. Frontiers in Cardiovascular Medicine. 10. 1298063–1298063. 1 indexed citations
6.
Liu, Xiangjuan, et al.. (2024). TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer. Translational Cancer Research. 13(8). 4159–4171. 1 indexed citations
7.
Hu, Can, et al.. (2024). Effects of Different Natural Drying Methods on Drying Characteristics and Quality of Diaogan apricots. Agriculture. 14(5). 660–660. 4 indexed citations
8.
Liu, Xiangjuan, et al.. (2024). Study on Heat and Mass Transfer Performance of Ultra-Thin Micro-Heat Pipes. Energies. 17(14). 3426–3426. 1 indexed citations
9.
Liu, Xiangjuan & Xibing Li. (2023). The Influence of Agricultural Production Mechanization on Grain Production Capacity and Efficiency. Processes. 11(2). 487–487. 16 indexed citations
10.
Liu, Xiangjuan, Yin Ren, Siyuan Wang, et al.. (2023). New insights into the cortex-to-stele ratio show it to effectively indicate inter- and intraspecific function in the absorptive roots of temperate trees. Frontiers in Plant Science. 14. 1061503–1061503. 4 indexed citations
11.
Zhao, Di, Wei Wang, Hao Wang, et al.. (2017). PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway. International Journal of Biological Sciences. 13(3). 276–285. 35 indexed citations
13.
Liu, Xiangjuan, Qun Xu, Zhuo Zhao, et al.. (2015). Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model. Pharmacological Research. 93. 43–51. 38 indexed citations
14.
Wang, Wenke, Ben Wang, Qinghua Lu, et al.. (2014). Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. International Journal of Cardiology. 172(1). 202–212. 85 indexed citations
15.
Wang, Wenke, Qinghua Lu, Ben Wang, et al.. (2014). HMGB1 mediates hyperglycaemia‐induced cardiomyocyte apoptosis via ERK/Ets‐1 signalling pathway. Journal of Cellular and Molecular Medicine. 18(11). 2311–2320. 62 indexed citations
16.
Luo, Beibei, Bo Li, Wenke Wang, et al.. (2014). NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model. PLoS ONE. 9(8). e104771–e104771. 356 indexed citations breakdown →
17.
Wang, Ben, Wenke Wang, Weibo Niu, et al.. (2013). SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6. Carcinogenesis. 35(2). 282–291. 60 indexed citations
18.
Luo, Beibei, Bo Li, Wenke Wang, et al.. (2013). Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model. Cardiovascular Drugs and Therapy. 28(1). 33–43. 132 indexed citations
19.
Liu, Xiangjuan, Funian Li, Dandan Jiang, et al.. (2012). [Regulation of p14(ARF) expression and induction of cell apoptosis with c-myc in a p53-independent pathway].. PubMed. 92(30). 2140–3. 2 indexed citations
20.
Qu, Xian‐Jun, Xue Xia, Yuanshu Wang, et al.. (2009). Protective effects of Salvia plebeia compound homoplantaginin on hepatocyte injury. Food and Chemical Toxicology. 47(7). 1710–1715. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026